Announce Date | 04/24/2025 |
EPS Normalized Actual | $0.42 (Beat by $0.0376) |
EPS GAAP Actual | $0.42 (Beat by $0.0376) |
Revenue Actual | $3.635B |
Revenue Surprise | Beat by $3635M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.48565 |
EPS GAAP Estimate | $0.48565 |
Revenue Estimate | $4.060721064B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.47054 | 13.68 | 2.42771 | 2.50184 | 2 |
Dec 2027 | 2.31611 | 14.59 | 2.27596 | 2.34545 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 3.635B | 4.59% | 3635M |
FQ4 2024 (Dec 2024) | 0 | 0 | 4.07B | 4.99% | 4070M |
FQ3 2024 (Sep 2024) | 0.45 | 0.45 | 3.891B | 2.21% | 3891M |
FQ2 2024 (Jun 2024) | 0.38 | 0.38 | 3.922B | 3.39% | 3922M |
FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 3.468B | 3.32% | 3468M |
FQ4 2023 (Dec 2023) | 0.5 | 0.5 | 3.867B | 1.66% | 3867M |
FQ3 2023 (Sep 2023) | 0.37 | 0.37 | 3.805B | 4.81% | 3805M |
FQ2 2023 (Jun 2023) | 0.36 | 0.36 | 3.789B | 100% | 3789M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.48565
Consensus Revenue Estimates
4.060721064B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.70584 | -- | 0.6827 | 0.71989 | 6 |
FQ3 2027 (Sep 2027) | 0.63318 | -- | 0.61242 | 0.64579 | 3 |
FQ2 2027 (Jun 2027) | 0.57662 | -- | 0.55771 | 0.5881 | 3 |
FQ1 2027 (Mar 2027) | 0.46694 | -- | 0.45163 | 0.47624 | 6 |
FQ4 2026 (Oct 2026) | 0.59896 | -- | 0.59226 | 0.60705 | 7 |
FQ3 2026 (Jul 2026) | 0.5189 | -- | 0.5131 | 0.5259 | 4 |
FQ2 2026 (Jun 2026) | 0.51843 | -- | 0.50846 | 0.52427 | 4 |
FQ1 2026 (Mar 2026) | 0.39283 | 3.27 | 0.38528 | 0.39725 | 4 |
FQ4 2025 (Oct 2025) | 0.56002 | -- | 0.55376 | 0.56758 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.64B | -- | 4.52B | 4.71B | 6 |
FQ3 2027 (Sep 2027) | 4.45B | -- | 4.33B | 4.51B | 3 |
FQ2 2027 (Jun 2027) | 4.48B | -- | 4.37B | 4.55B | 3 |
FQ1 2027 (Mar 2027) | 3.96B | -- | 3.86B | 4.02B | 3 |
FQ4 2026 (Oct 2026) | 4.27B | -- | 4.23B | 4.31B | 4 |
FQ3 2026 (Jul 2026) | 4.2B | -- | 4.17B | 4.25B | 4 |
FQ2 2026 (Jun 2026) | 4.18B | -- | 4.12B | 4.22B | 4 |
FQ1 2026 (Mar 2026) | 3.64B | 0.2 | 3.59B | 3.67B | 7 |
FQ4 2025 (Oct 2025) | 4.11B | 0.97 | 4.07B | 4.15B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.45 | 0.45 | 100% | |
FQ2 2024 (Jun 2024) | 0.38 | 0.38 | 100% | |
FQ1 2024 (Mar 2024) | 0.33 | 0.33 | 100% | |
FQ4 2023 (Dec 2023) | 0.5 | 0.5 | 100% | |
FQ3 2023 (Sep 2023) | 0.37 | 0.37 | 100% | |
FQ2 2023 (Jun 2023) | 0.36 | 0.36 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.64B | $3635M | 100% |
FQ4 2024 (Dec 2024) | $0B | $4.07B | $4070M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.89B | $3891M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.92B | $3922M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.47B | $3468M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.87B | $3867M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.81B | $3805M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.79B | $3789M | 100% |